Solid Biosciences Statistics Share Statistics Solid Biosciences has 77.52M
shares outstanding. The number of shares has increased by 100.84%
in one year.
Shares Outstanding 77.52M Shares Change (YoY) 100.84% Shares Change (QoQ) 0.03% Owned by Institutions (%) 99.99% Shares Floating 56.53M Failed to Deliver (FTD) Shares 1,320 FTD / Avg. Volume 0.08%
Short Selling Information The latest short interest is 10.23M, so 13.2% of the outstanding
shares have been sold short.
Short Interest 10.23M Short % of Shares Out 13.2% Short % of Float 15.7% Short Ratio (days to cover) 9.22
Valuation Ratios The PE ratio is -1.31 and the forward
PE ratio is -2.91.
Solid Biosciences's PEG ratio is
0.04.
PE Ratio -1.31 Forward PE -2.91 PS Ratio 0 Forward PS 127.6 PB Ratio 1.19 P/FCF Ratio -1.62 PEG Ratio 0.04
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Solid Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.2,
with a Debt / Equity ratio of 0.18.
Current Ratio 5.2 Quick Ratio 5.2 Debt / Equity 0.18 Debt / EBITDA -0.2 Debt / FCF -0.24 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.25M Employee Count 100 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -15.36% in the
last 52 weeks. The beta is 2.44, so Solid Biosciences's
price volatility has been higher than the market average.
Beta 2.44 52-Week Price Change -15.36% 50-Day Moving Average 5.34 200-Day Moving Average 4.53 Relative Strength Index (RSI) 53.91 Average Volume (20 Days) 1,678,875
Income Statement
Revenue n/a Gross Profit -2.46M Operating Income -129.73M Net Income -124.7M EBITDA -121.9M EBIT -125.04M Earnings Per Share (EPS) -3.06
Full Income Statement Balance Sheet The company has 80.23M in cash and 24.18M in
debt, giving a net cash position of 56.06M.
Cash & Cash Equivalents 80.23M Total Debt 24.18M Net Cash 56.06M Retained Earnings -783.45M Total Assets 343.9M Working Capital 284.63M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -100.01M
and capital expenditures -654K, giving a free cash flow of -100.67M.
Operating Cash Flow -100.01M Capital Expenditures -654K Free Cash Flow -100.67M FCF Per Share -2.47
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields SLDB does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for SLDB is $15.5,
which is 155.8% higher than the current price. The consensus rating is "Buy".
Price Target $15.5 Price Target Difference 155.8% Analyst Consensus Buy Analyst Count 11
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 28, 2022. It was a
backward
split with a ratio of 1:15.
Last Split Date Oct 28, 2022 Split Type backward Split Ratio 1:15
Scores Altman Z-Score 2.22 Piotroski F-Score 1
